Skip to main content
Top
Published in: AIDS and Behavior 8/2015

01-08-2015 | Original Paper

Psychosocial and Neurohormonal Predictors of HIV Disease Progression (CD4 Cells and Viral Load): A 4 Year Prospective Study

Authors: G. Ironson, C. O’Cleirigh, M. Kumar, L. Kaplan, E. Balbin, C. B. Kelsch, M. A. Fletcher, N. Schneiderman

Published in: AIDS and Behavior | Issue 8/2015

Login to get access

Abstract

Most studies of psychosocial predictors of disease progression in HIV have not considered norepinephrine (NE), a neurohormone related to emotion and stress, even though NE has been related to accelerated viral replication in vitro and impaired response to antiretrovial therapy (ART). We therefore examined NE, cortisol, depression, hopelessness, coping, and life event stress as predictors of HIV progression in a diverse sample. Participants (n = 177) completed psychological assessment, blood draws [CD4, viral load (VL)], and a 15 h urine sample (NE, cortisol) every 6 months over 4 years. Hierarchical linear modeling (HLM) was used to model slope in CD4 and VL controlling for ART at every time point, gender, age, race, SES, and initial disease status. NE (as well as depression, hopelessness, and avoidant coping) significantly predicted a greater rate of decrease in CD4 and increase in VL. Cortisol was not significantly related to CD4, but predicted VL increase. To our knowledge, this is the first study relating NE, in vivo, to accelerated disease progression over an extended time. It also extends our previous 2 year study by relating depressed mood and coping to accelerated disease progression over 4 years.
Literature
1.
go back to reference Mayne TJ, Vittinghoff E, Chesney MA, Barrett DC, Coates TJ. Depressive affect and survival among gay and bisexual men infected with HIV. Arch Intern Med. 1996;156:2233–8.PubMedCrossRef Mayne TJ, Vittinghoff E, Chesney MA, Barrett DC, Coates TJ. Depressive affect and survival among gay and bisexual men infected with HIV. Arch Intern Med. 1996;156:2233–8.PubMedCrossRef
2.
go back to reference Leserman J, Petitto JM, Golden RN, et al. Impact of stressful life events, depression, social support, coping and cortisol on progression to AIDS. Am J Psychiatry. 2000;157(8):1221–8.PubMedCrossRef Leserman J, Petitto JM, Golden RN, et al. Impact of stressful life events, depression, social support, coping and cortisol on progression to AIDS. Am J Psychiatry. 2000;157(8):1221–8.PubMedCrossRef
3.
go back to reference Ickovics JR, Hamburger ME, Vlahov D, et al. Mortality, CD4 cell count decline, and depressive symptoms among HIV-seropositive women: longitudinal analysis from the HIV Epidemiology Research Study. JAMA. 2001;285:1460–5.CrossRef Ickovics JR, Hamburger ME, Vlahov D, et al. Mortality, CD4 cell count decline, and depressive symptoms among HIV-seropositive women: longitudinal analysis from the HIV Epidemiology Research Study. JAMA. 2001;285:1460–5.CrossRef
4.
go back to reference Leserman J. HIV disease progression: depression, stress, and possible mechanisms. Biol Psychiatry. 2003;54(3):295–306.PubMedCrossRef Leserman J. HIV disease progression: depression, stress, and possible mechanisms. Biol Psychiatry. 2003;54(3):295–306.PubMedCrossRef
5.
go back to reference Burack JH, Barrett DC, Stall RD, Chesney MA, Ekstrand ML, Coates TJ. Depressive symptoms and CD4 lymphocyte decline among HIV-infected men. JAMA. 1993;270(21):2568–73.PubMedCrossRef Burack JH, Barrett DC, Stall RD, Chesney MA, Ekstrand ML, Coates TJ. Depressive symptoms and CD4 lymphocyte decline among HIV-infected men. JAMA. 1993;270(21):2568–73.PubMedCrossRef
6.
go back to reference Blashill AJ, Perry N, Safren SA. Mental health: a focus on stress, coping, and mental illness as it relates to treatment retention, adherence, and other health outcomes. Curr HIV/AIDS Rep. 2011;8:215–22.PubMedCentralPubMedCrossRef Blashill AJ, Perry N, Safren SA. Mental health: a focus on stress, coping, and mental illness as it relates to treatment retention, adherence, and other health outcomes. Curr HIV/AIDS Rep. 2011;8:215–22.PubMedCentralPubMedCrossRef
7.
go back to reference Ironson G, Balbin E, Stieren E, et al. Perceived stress and norepinephrine predict the effectiveness of response to protease inhibitors in HIV. Int J Behav Med. 2008;15:221–6.PubMedCentralPubMedCrossRef Ironson G, Balbin E, Stieren E, et al. Perceived stress and norepinephrine predict the effectiveness of response to protease inhibitors in HIV. Int J Behav Med. 2008;15:221–6.PubMedCentralPubMedCrossRef
8.
go back to reference Temoshok LR, Waldstein SR, Wald RL, et al. Type C coping, alexithymia, and heart rate reactivity are associated independently and differentially with specific immune mechanisms linked to HIV progression. Brain Behav Immun. 2008;22(5):781–92.PubMedCrossRef Temoshok LR, Waldstein SR, Wald RL, et al. Type C coping, alexithymia, and heart rate reactivity are associated independently and differentially with specific immune mechanisms linked to HIV progression. Brain Behav Immun. 2008;22(5):781–92.PubMedCrossRef
9.
go back to reference Pence BW, O’Donnell JK, Gaynes BN. Falling through the cracks: the gaps between depression prevalence, diagnosis, treatment, and response in HIV care. AIDS. 2012;26(5):656–8.PubMedCentralPubMedCrossRef Pence BW, O’Donnell JK, Gaynes BN. Falling through the cracks: the gaps between depression prevalence, diagnosis, treatment, and response in HIV care. AIDS. 2012;26(5):656–8.PubMedCentralPubMedCrossRef
10.
go back to reference Leserman J, Petitto JM, Gu H, et al. Progression to AIDS, a clinical AIDS condition and mortality: psychosocial and physiological predictors. Psychol Med. 2002;32(6):1059–73.PubMedCrossRef Leserman J, Petitto JM, Gu H, et al. Progression to AIDS, a clinical AIDS condition and mortality: psychosocial and physiological predictors. Psychol Med. 2002;32(6):1059–73.PubMedCrossRef
11.
go back to reference Segerstrom SC, Miller GE. Psychological stress and the human immune system: a meta-analytic study of 30 years of inquiry. Psychol Bull. 2004;130:601–30.PubMedCentralPubMedCrossRef Segerstrom SC, Miller GE. Psychological stress and the human immune system: a meta-analytic study of 30 years of inquiry. Psychol Bull. 2004;130:601–30.PubMedCentralPubMedCrossRef
12.
go back to reference Fekete EM, Antoni MH, Lopez C, et al. Stress buffering effects of oxytocin on HIV status in low-income ethnic minority women. Psychoneuroendocrinology. 2011;36(6):881–90.PubMedCentralPubMedCrossRef Fekete EM, Antoni MH, Lopez C, et al. Stress buffering effects of oxytocin on HIV status in low-income ethnic minority women. Psychoneuroendocrinology. 2011;36(6):881–90.PubMedCentralPubMedCrossRef
13.
go back to reference Hussain D. Stress, immunity, and health: research findings and implications. IJPR. 2010;15:94–100. Hussain D. Stress, immunity, and health: research findings and implications. IJPR. 2010;15:94–100.
14.
go back to reference Machtinger EL, Wilson TC, Haberer JE, Weiss DS. Psychological trauma and PTSD in HIV-positive women: a meta-analysis. AIDS Behav. 2012;16:2091–100.PubMedCrossRef Machtinger EL, Wilson TC, Haberer JE, Weiss DS. Psychological trauma and PTSD in HIV-positive women: a meta-analysis. AIDS Behav. 2012;16:2091–100.PubMedCrossRef
15.
go back to reference Rose RC, House AS, Stepleman LM. Intimate partner violence and its effects on the health of African American HIV-positive women. Psychol Trauma. 2010;2:311–7.CrossRef Rose RC, House AS, Stepleman LM. Intimate partner violence and its effects on the health of African American HIV-positive women. Psychol Trauma. 2010;2:311–7.CrossRef
16.
go back to reference Ironson G, Cruess D, Kumar M. Immune and neuroendocrine alterations in post-traumatic stress disorder. Psychoneuroimmunology. 2004;25(1):531–47. Ironson G, Cruess D, Kumar M. Immune and neuroendocrine alterations in post-traumatic stress disorder. Psychoneuroimmunology. 2004;25(1):531–47.
17.
18.
go back to reference Patterson TL, Semple SJ, Temoshok LR, et al. Stress and depressive symptoms prospectively predict immune change among HIV-seropositive men. Psychiatry. 1995;58(4):299–312.PubMed Patterson TL, Semple SJ, Temoshok LR, et al. Stress and depressive symptoms prospectively predict immune change among HIV-seropositive men. Psychiatry. 1995;58(4):299–312.PubMed
19.
go back to reference Ironson G, O’Cleirigh C, Fletcher MA, et al. Psychosocial factors predict CD4 and viral load change in men and women in the era of HAART. Psychol Med. 2005;67(6):1013–21.CrossRef Ironson G, O’Cleirigh C, Fletcher MA, et al. Psychosocial factors predict CD4 and viral load change in men and women in the era of HAART. Psychol Med. 2005;67(6):1013–21.CrossRef
20.
go back to reference Ironson G, Friedman A, Klimas N, et al. Distress, denial, and low adherence to behavioral interventions predict faster disease progression in gay men infected with human immunodeficiency virus. Int J Behav Med. 1994;1:90–105.PubMedCrossRef Ironson G, Friedman A, Klimas N, et al. Distress, denial, and low adherence to behavioral interventions predict faster disease progression in gay men infected with human immunodeficiency virus. Int J Behav Med. 1994;1:90–105.PubMedCrossRef
21.
go back to reference Remor E, Penedo FJ, Shen BJ, Schneiderman N. Perceived stress is associated with CD4+ cell decline in men and women living with HIV/AIDS in Spain. AIDS Care. 2007;19(2):215–9.PubMedCrossRef Remor E, Penedo FJ, Shen BJ, Schneiderman N. Perceived stress is associated with CD4+ cell decline in men and women living with HIV/AIDS in Spain. AIDS Care. 2007;19(2):215–9.PubMedCrossRef
22.
go back to reference Ghebremichael M, Paintsil E, Ickovics JR, et al. Longitudinal association of alcohol use with HIV disease progression and psychological health of women with HIV. AIDS Care. 2009;2009(21):834–41.CrossRef Ghebremichael M, Paintsil E, Ickovics JR, et al. Longitudinal association of alcohol use with HIV disease progression and psychological health of women with HIV. AIDS Care. 2009;2009(21):834–41.CrossRef
23.
go back to reference Carrico AW, Riley ED, Johnson MO, et al. Psychiatric risk factors for HIV disease progression: the role of inconsistent patterns of anti-retroviral therapy utilization. J AIDS. 2011;56(2):146–50. Carrico AW, Riley ED, Johnson MO, et al. Psychiatric risk factors for HIV disease progression: the role of inconsistent patterns of anti-retroviral therapy utilization. J AIDS. 2011;56(2):146–50.
24.
go back to reference Alemu H, Mariam DH, Tsui A, Ahmed S, Shewamare A. Effect of depressive symptoms and social support on weight and CD4 count increase at HIV clinic in Ethiopia. AIDS Care. 2012;24:866–76.PubMedCrossRef Alemu H, Mariam DH, Tsui A, Ahmed S, Shewamare A. Effect of depressive symptoms and social support on weight and CD4 count increase at HIV clinic in Ethiopia. AIDS Care. 2012;24:866–76.PubMedCrossRef
25.
go back to reference Antelman G, Kaaya S, Wei R, et al. Depressive symptoms increase risk of HIV disease progression and mortality among women in Tanzania. J Acquir Immune Defic Syndr. 2007;44:470–7.PubMedCrossRef Antelman G, Kaaya S, Wei R, et al. Depressive symptoms increase risk of HIV disease progression and mortality among women in Tanzania. J Acquir Immune Defic Syndr. 2007;44:470–7.PubMedCrossRef
26.
go back to reference Bouhnik AD, Preau M, Vincent E, et al. Depression and clinical progression in HIV-infected drug users treated with highly active antiretroviral therapy. Antivir Ther. 2005;10(1):53–61.PubMed Bouhnik AD, Preau M, Vincent E, et al. Depression and clinical progression in HIV-infected drug users treated with highly active antiretroviral therapy. Antivir Ther. 2005;10(1):53–61.PubMed
27.
go back to reference Chida Y, Vedhara K. Adverse psychosocial factors predict poorer prognosis in HIV disease: a meta-analytic review of prospective investigations. Brain Behav Immun. 2009;23:434–45.PubMedCrossRef Chida Y, Vedhara K. Adverse psychosocial factors predict poorer prognosis in HIV disease: a meta-analytic review of prospective investigations. Brain Behav Immun. 2009;23:434–45.PubMedCrossRef
28.
go back to reference Kopnisky KL, Stoff DM, Rausch DM. Workshop report: the effects of psychological variables on the progression of HIV-1 disease. Brain Behav Immun. 2004;18:246–61.PubMedCrossRef Kopnisky KL, Stoff DM, Rausch DM. Workshop report: the effects of psychological variables on the progression of HIV-1 disease. Brain Behav Immun. 2004;18:246–61.PubMedCrossRef
29.
30.
go back to reference Cole SW. Psychosocial influences on HIV-1 disease progression: neural, endocrine, and virologic mechanisms. Psychosom Med. 2008;70:562–8.PubMedCrossRef Cole SW. Psychosocial influences on HIV-1 disease progression: neural, endocrine, and virologic mechanisms. Psychosom Med. 2008;70:562–8.PubMedCrossRef
31.
go back to reference Cole SW, Korin YD, Fahey JL, Zack JA. Norepinephrine accelerates HIV replication via protein kinase A-dependent effects on cytokine production. J Immunol. 1998;161:610–6.PubMed Cole SW, Korin YD, Fahey JL, Zack JA. Norepinephrine accelerates HIV replication via protein kinase A-dependent effects on cytokine production. J Immunol. 1998;161:610–6.PubMed
32.
go back to reference Cole SW, Jamieson BD, Zack JA. cAMP externalizes lymphocyte CXCR4: implications for chemotaxis and HIV infection. J Immunol. 1999;162:1392–400.PubMed Cole SW, Jamieson BD, Zack JA. cAMP externalizes lymphocyte CXCR4: implications for chemotaxis and HIV infection. J Immunol. 1999;162:1392–400.PubMed
33.
go back to reference Cole SW, Kemeny ME, Fahey JL, Zack JA, Naliboff BD. Psychological risk factors for HIV pathogenesis: mediation by the autonomic nervous system. Biol Psychiatry. 2003;54:1444–56.PubMedCrossRef Cole SW, Kemeny ME, Fahey JL, Zack JA, Naliboff BD. Psychological risk factors for HIV pathogenesis: mediation by the autonomic nervous system. Biol Psychiatry. 2003;54:1444–56.PubMedCrossRef
34.
go back to reference Collado-Hidalgo A, Sung C, Cole S. Adrenergic inhibition of innate anti-viral response: PKA blockade of Type I interferon gene transcription mediates catecholamine support for HIV-1 replication. Brain Behav Immun. 2006;20:552–63.PubMedCrossRef Collado-Hidalgo A, Sung C, Cole S. Adrenergic inhibition of innate anti-viral response: PKA blockade of Type I interferon gene transcription mediates catecholamine support for HIV-1 replication. Brain Behav Immun. 2006;20:552–63.PubMedCrossRef
35.
go back to reference Sloan EK, Capitanio JP, Tarara RP, Mendoza SP, Mason WA, Cole SW. Social stress enhances sympathetic innervation of primate lymph nodes: mechanisms and implications for viral pathogenesis. J Neurosci. 2007;27:8857–65.PubMedCrossRef Sloan EK, Capitanio JP, Tarara RP, Mendoza SP, Mason WA, Cole SW. Social stress enhances sympathetic innervation of primate lymph nodes: mechanisms and implications for viral pathogenesis. J Neurosci. 2007;27:8857–65.PubMedCrossRef
36.
go back to reference Cole SW, Naliboff BD, Kemeny ME, Griswold MP, Fahey JL, Zack JA. Impaired response to HAART in HIV-infected individuals with high autonomic nervous system activity. Proc Natl Acad Sci. 2001;98:12695–700.PubMedCentralPubMedCrossRef Cole SW, Naliboff BD, Kemeny ME, Griswold MP, Fahey JL, Zack JA. Impaired response to HAART in HIV-infected individuals with high autonomic nervous system activity. Proc Natl Acad Sci. 2001;98:12695–700.PubMedCentralPubMedCrossRef
37.
go back to reference Munck A, Guyre PM. Glucocorticoids and immune function. In: Ader R, Felton DL, Cohen N, editors. Psychoneuroimmunology. 2nd ed. San Diego: Academic Press; 1991. Munck A, Guyre PM. Glucocorticoids and immune function. In: Ader R, Felton DL, Cohen N, editors. Psychoneuroimmunology. 2nd ed. San Diego: Academic Press; 1991.
38.
go back to reference Markham PD, Salahuddin SZ, Veren K, Orndorff S, Gallo R. Hydrocortisone and some other hormones enhance the expression of HTLV-III. Int J Cancer. 1986;37:67–72.PubMedCrossRef Markham PD, Salahuddin SZ, Veren K, Orndorff S, Gallo R. Hydrocortisone and some other hormones enhance the expression of HTLV-III. Int J Cancer. 1986;37:67–72.PubMedCrossRef
39.
go back to reference Kino T, Kopp JB, Chrousos GP. Glucocorticoids suppress human immunodeficiency virus type-1 long terminal repeat activity in a cell type-specific, glucocorticoid receptor-mediated fashion: direct protective effects at variance with clinical phenomenology. J Steroid Biochem Mol Biol. 2000;75:283–90.PubMedCrossRef Kino T, Kopp JB, Chrousos GP. Glucocorticoids suppress human immunodeficiency virus type-1 long terminal repeat activity in a cell type-specific, glucocorticoid receptor-mediated fashion: direct protective effects at variance with clinical phenomenology. J Steroid Biochem Mol Biol. 2000;75:283–90.PubMedCrossRef
40.
go back to reference Mellman TA, Kumar AM, Kulick-Bell R, Kumar M, Nolan B. Nocturnal/daytime urine noradrenergic measures and sleep in combat related PTSD. Biol Psychiatry. 1995;38:174–9.PubMedCrossRef Mellman TA, Kumar AM, Kulick-Bell R, Kumar M, Nolan B. Nocturnal/daytime urine noradrenergic measures and sleep in combat related PTSD. Biol Psychiatry. 1995;38:174–9.PubMedCrossRef
41.
go back to reference Kumar AM, Kumar M, Fernandez JB, Mellman TA, Eisdorfer C. A simplified HPLC-ECD technique for measurement of urinary free catecholamines. J Liq Chromatogr. 1991;14:3547–57.CrossRef Kumar AM, Kumar M, Fernandez JB, Mellman TA, Eisdorfer C. A simplified HPLC-ECD technique for measurement of urinary free catecholamines. J Liq Chromatogr. 1991;14:3547–57.CrossRef
42.
go back to reference Beck AT. Depression: causes and treatment. Philadelphia: University of Pennsylvania Press; 1976. Beck AT. Depression: causes and treatment. Philadelphia: University of Pennsylvania Press; 1976.
43.
go back to reference Kendall PC, Hollon SD, Beck AT, Hammen CL, Ingram RE. Issues and recommendations regarding use of the Beck Depression Inventory. Cogn Ther Res. 1987;11(3):289–99.CrossRef Kendall PC, Hollon SD, Beck AT, Hammen CL, Ingram RE. Issues and recommendations regarding use of the Beck Depression Inventory. Cogn Ther Res. 1987;11(3):289–99.CrossRef
44.
go back to reference Beck AT, Weissman A, Lester D, Trexler L. The measurement of pessimism: the Hopelessness Scale. J Consult Clin Psychol. 1974;42:861–5.PubMedCrossRef Beck AT, Weissman A, Lester D, Trexler L. The measurement of pessimism: the Hopelessness Scale. J Consult Clin Psychol. 1974;42:861–5.PubMedCrossRef
45.
go back to reference Carver CS, Scheier MF, Weintraub JK. Assessing coping strategies: a theoretically based approach. J Pers Soc Psychol. 1989;56:267–83.PubMedCrossRef Carver CS, Scheier MF, Weintraub JK. Assessing coping strategies: a theoretically based approach. J Pers Soc Psychol. 1989;56:267–83.PubMedCrossRef
46.
go back to reference Sarason IG, Johnson J, Siegel J. Assessing the impact of life changes: development of the Life Experiences Survey. J Consult Clin Psychol. 1978;46:932–46.PubMedCrossRef Sarason IG, Johnson J, Siegel J. Assessing the impact of life changes: development of the Life Experiences Survey. J Consult Clin Psychol. 1978;46:932–46.PubMedCrossRef
47.
go back to reference Chesney MA, Ickovics JR, Chambers DB, et al. Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: the AACTG adherence instruments. Patient Care Committee and Adherence Working Group of the Outcomes Committee of the Adult AIDS Clinical Trials Group (AACTG). AIDS Care. 2000;12(3):255–66.PubMedCrossRef Chesney MA, Ickovics JR, Chambers DB, et al. Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: the AACTG adherence instruments. Patient Care Committee and Adherence Working Group of the Outcomes Committee of the Adult AIDS Clinical Trials Group (AACTG). AIDS Care. 2000;12(3):255–66.PubMedCrossRef
48.
go back to reference Bryk AS, Raudenbush SW. Hierarchical linear models: applications and data analysis methods. 2nd ed. Thousand Oaks: Sage; 2002. Bryk AS, Raudenbush SW. Hierarchical linear models: applications and data analysis methods. 2nd ed. Thousand Oaks: Sage; 2002.
49.
go back to reference Raudenbush SW, Bryk AS, Cheong YF, Congdon RC. HLM5: hierarchical linear and nonlinear modeling. Lincolnwood: Scientific Software International; 2002. Raudenbush SW, Bryk AS, Cheong YF, Congdon RC. HLM5: hierarchical linear and nonlinear modeling. Lincolnwood: Scientific Software International; 2002.
50.
go back to reference Beck AT, Brown G, Berchick RJ, Stewart BL, Steer RA. Relationship between hopelessness and ultimate suicide: a replication with psychiatric outpatients. Am J Psychiatry. 1990;147:190–5.PubMedCrossRef Beck AT, Brown G, Berchick RJ, Stewart BL, Steer RA. Relationship between hopelessness and ultimate suicide: a replication with psychiatric outpatients. Am J Psychiatry. 1990;147:190–5.PubMedCrossRef
51.
go back to reference Sundstrom JB, Martinson D, Mosunjac M, et al. Norepinephrine enhances adhesion of HIV-1-infected leukocytes to cardiac microvascular endothelial cells. Exp Biol Med. 2003;228:730–40. Sundstrom JB, Martinson D, Mosunjac M, et al. Norepinephrine enhances adhesion of HIV-1-infected leukocytes to cardiac microvascular endothelial cells. Exp Biol Med. 2003;228:730–40.
52.
go back to reference Christeff N, Gherbi N, Mammes O, et al. Serum cortisol and DHEA concentrations during HIV infection. Psychoneuroendocrinology. 1997;22(suppl 1):S11–8.PubMedCrossRef Christeff N, Gherbi N, Mammes O, et al. Serum cortisol and DHEA concentrations during HIV infection. Psychoneuroendocrinology. 1997;22(suppl 1):S11–8.PubMedCrossRef
53.
go back to reference Mayo J, Collazos J, Martinez E, Ibarra S. Adrenal function in the HIV infected patient. Arch Intern Med. 2002;162(10):1095–8.PubMedCrossRef Mayo J, Collazos J, Martinez E, Ibarra S. Adrenal function in the HIV infected patient. Arch Intern Med. 2002;162(10):1095–8.PubMedCrossRef
54.
go back to reference Chittiprol S, Kumar AM, Shetty KT, et al. HIV-1 clade C infection and progressive disruption in the relationship between cortisol, DHEAS and CD4 cell numbers: a two-year follow-up study. Clin Chim Acta. 2009;409:4–10.PubMedCentralPubMedCrossRef Chittiprol S, Kumar AM, Shetty KT, et al. HIV-1 clade C infection and progressive disruption in the relationship between cortisol, DHEAS and CD4 cell numbers: a two-year follow-up study. Clin Chim Acta. 2009;409:4–10.PubMedCentralPubMedCrossRef
56.
57.
go back to reference Markowitz J, Kocsis J, Fishman B, et al. Treatment of depressive symptoms in HIV-positive patients. Arch Gen Psychiatry. 1998;55:452–7.PubMedCrossRef Markowitz J, Kocsis J, Fishman B, et al. Treatment of depressive symptoms in HIV-positive patients. Arch Gen Psychiatry. 1998;55:452–7.PubMedCrossRef
58.
go back to reference Rabkin J, Wagner G, Rabkin R. Fluoxetine treatment for depression in patients with HIV and AIDS: a randomized, placebo-controlled trial. Am J Psychiatry. 1999;156:101–7.PubMedCrossRef Rabkin J, Wagner G, Rabkin R. Fluoxetine treatment for depression in patients with HIV and AIDS: a randomized, placebo-controlled trial. Am J Psychiatry. 1999;156:101–7.PubMedCrossRef
59.
go back to reference Safren S, Hendriksen E, Mayer K, Mimiaga M, Pickard R, Otto M. Cognitive behavioral therapy for HIV medication adherence and depression. Cog Behav Pract. 2004;11:415–23.CrossRef Safren S, Hendriksen E, Mayer K, Mimiaga M, Pickard R, Otto M. Cognitive behavioral therapy for HIV medication adherence and depression. Cog Behav Pract. 2004;11:415–23.CrossRef
60.
go back to reference Crepaz N, Passin WF, Herbst JH, et al. Meta-analysis of cognitive-behavioral interventions on HIV-positive persons’ mental health and immune functioning. Health Psychol. 2008;2008(27):4–14.CrossRef Crepaz N, Passin WF, Herbst JH, et al. Meta-analysis of cognitive-behavioral interventions on HIV-positive persons’ mental health and immune functioning. Health Psychol. 2008;2008(27):4–14.CrossRef
61.
go back to reference Antoni MH, Cruess DG, Cruess S, et al. Cognitive-behavioral stress management intervention effects on anxiety, 24-hr urinary norepinephrine output, and T-cytotoxic/suppressor cells over time among symptomatic HIV-infected gay men. J Consult Clin Psychol. 2000;68:31–45.PubMedCrossRef Antoni MH, Cruess DG, Cruess S, et al. Cognitive-behavioral stress management intervention effects on anxiety, 24-hr urinary norepinephrine output, and T-cytotoxic/suppressor cells over time among symptomatic HIV-infected gay men. J Consult Clin Psychol. 2000;68:31–45.PubMedCrossRef
62.
go back to reference Scott-Sheldon LA, Kalichman SC, Carey MP, Fielder RL. Stress management interventions for HIV+ adults: a meta-analysis of randomized controlled trials, 1989 to 2006. Health Psychol. 2008;27:129–39.PubMedCentralPubMedCrossRef Scott-Sheldon LA, Kalichman SC, Carey MP, Fielder RL. Stress management interventions for HIV+ adults: a meta-analysis of randomized controlled trials, 1989 to 2006. Health Psychol. 2008;27:129–39.PubMedCentralPubMedCrossRef
63.
go back to reference Antoni MH, Carrico AW, Durán RE, et al. Randomized clinical trial of cognitive behavioral stress management on human immunodeficiency virus viral load in gay men treated with highly active antiretroviral therapy. Psychosom Med. 2006;68:143–51.PubMedCrossRef Antoni MH, Carrico AW, Durán RE, et al. Randomized clinical trial of cognitive behavioral stress management on human immunodeficiency virus viral load in gay men treated with highly active antiretroviral therapy. Psychosom Med. 2006;68:143–51.PubMedCrossRef
64.
go back to reference Saag MS, Holodnly M, Kuirzkes DR, et al. HIV viral load markers in clinical practice. Nat Med. 1996;2:625–9.PubMedCrossRef Saag MS, Holodnly M, Kuirzkes DR, et al. HIV viral load markers in clinical practice. Nat Med. 1996;2:625–9.PubMedCrossRef
65.
go back to reference Powderly WG, Landry A, Lederman M. Recovery of the immune system with antiretroviral therapy; the end of opportunism? JAMA. 1998;280:72–7.PubMedCrossRef Powderly WG, Landry A, Lederman M. Recovery of the immune system with antiretroviral therapy; the end of opportunism? JAMA. 1998;280:72–7.PubMedCrossRef
66.
go back to reference Ironson G, Solomon S, Balbin E, et al. The Ironson-Woods Spirituality/Religiousness Index is associated with long survival, health behaviors, less distress and low cortisol in people with HIV/AIDS. Ann Behav Med. 2002;24:34–48.PubMedCrossRef Ironson G, Solomon S, Balbin E, et al. The Ironson-Woods Spirituality/Religiousness Index is associated with long survival, health behaviors, less distress and low cortisol in people with HIV/AIDS. Ann Behav Med. 2002;24:34–48.PubMedCrossRef
67.
go back to reference Ironson G, Cruess D, Kelsch CB, et al. Posttraumatic stress symptoms, intrusive thoughts, and disruption are longitudinally related to elevated cortisol and catecholamines following a major hurricane. JABR. 2014;19:24–52. Ironson G, Cruess D, Kelsch CB, et al. Posttraumatic stress symptoms, intrusive thoughts, and disruption are longitudinally related to elevated cortisol and catecholamines following a major hurricane. JABR. 2014;19:24–52.
Metadata
Title
Psychosocial and Neurohormonal Predictors of HIV Disease Progression (CD4 Cells and Viral Load): A 4 Year Prospective Study
Authors
G. Ironson
C. O’Cleirigh
M. Kumar
L. Kaplan
E. Balbin
C. B. Kelsch
M. A. Fletcher
N. Schneiderman
Publication date
01-08-2015
Publisher
Springer US
Published in
AIDS and Behavior / Issue 8/2015
Print ISSN: 1090-7165
Electronic ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-014-0877-x

Other articles of this Issue 8/2015

AIDS and Behavior 8/2015 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine